These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11078417)

  • 41. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure.
    Sakai S; Miyauchi T; Kobayashi M; Yamaguchi I; Goto K; Sugishita Y
    Nature; 1996 Nov; 384(6607):353-5. PubMed ID: 8934519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
    Spieker LE; Noll G; Ruschitzka FT; Lüscher TF
    J Am Coll Cardiol; 2001 May; 37(6):1493-505. PubMed ID: 11345356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiac microvasculature in DOCA-salt hypertensive rats : effect of endothelin ET(A) receptor antagonism.
    Larouche I; Schiffrin EL
    Hypertension; 1999 Oct; 34(4 Pt 2):795-801. PubMed ID: 10523363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal endothelin system in diabetes: comparison of angiotensin-converting enzyme inhibition and endothelin-A antagonism.
    Hocher B; Lun A; Priem F; Neumayer HH; Raschack M
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S492-5. PubMed ID: 9595522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic potential for endothelin receptor antagonists in cardiovascular disorders.
    Spieker LE; Noll G; Lüscher TF
    Am J Cardiovasc Drugs; 2001; 1(4):293-303. PubMed ID: 14728028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of losartan and captopril on endothelin-1 production in blood vessels and glomeruli of rats with reduced renal mass.
    Larivière R; Lebel M; Kingma I; Grose JH; Boucher D
    Am J Hypertens; 1998 Aug; 11(8 Pt 1):989-97. PubMed ID: 9715793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thromboxane blockade reduces blood pressure and progression of renal failure independent of endothelin-1 in uremic rats.
    Larivière R; Moreau C; Rodrigue ME; Lebel M
    Prostaglandins Leukot Essent Fatty Acids; 2004 Aug; 71(2):103-9. PubMed ID: 15207526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes.
    Benigni A; Colosio V; Brena C; Bruzzi I; Bertani T; Remuzzi G
    Diabetes; 1998 Mar; 47(3):450-6. PubMed ID: 9519753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of anemia and uremia and a combination of both on cardiovascular structures.
    Jürgensen JS; Grimm R; Benz K; Philipp S; Eckardt KU; Amann K
    Kidney Blood Press Res; 2010; 33(4):274-81. PubMed ID: 20628260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renin-angiotensin system blockade alone or combined with ET
    Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
    Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats.
    Ehmke H; Faulhaber J; Münter K; Kirchengast M; Wiesner RJ
    Hypertension; 1999 Apr; 33(4):954-60. PubMed ID: 10205230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats.
    Dumont Y; D'Amours M; Lebel M; Larivière R
    Nephrol Dial Transplant; 2001 Apr; 16(4):746-54. PubMed ID: 11274268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of renal blood flow by endogenous endothelin-1 in conscious rabbits with left ventricular dysfunction.
    Muders F; Luchner A; Friedrich EB; Ickenstein G; Riegger GA; Elsner D
    Am J Hypertens; 1999 Aug; 12(8 Pt 1):835-8. PubMed ID: 10480479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of selective endothelin (ET)-A receptor antagonist versus dual ET-A/B receptor antagonist on hearts of streptozotocin-treated diabetic rats.
    Miyauchi Y; Jesmin S; Sakai S; Kamiyama J; Shimojo N; Rahman A; Islam M; Zaedi S; Maeda S; Maruyama H; Mizutani T; Homma S; Aonuma K; Miyauchi T
    Life Sci; 2014 Aug; 111(1-2):6-11. PubMed ID: 24953608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bosentan the mixed endothelin-A- and -B-receptor antagonist suppresses intrapericardial endothelin-1-induced ventricular arrhythmias.
    Horkay F; Gellér L; Kiss O; Szabó T; Vagó H; Kékesi V; Juhász-Nagy A; Merkely B
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S320-2. PubMed ID: 11078409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition.
    Ortmann J; Amann K; Brandes RP; Kretzler M; Münter K; Parekh N; Traupe T; Lange M; Lattmann T; Barton M
    Hypertension; 2004 Dec; 44(6):974-81. PubMed ID: 15545511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stimulation of serum- and glucocorticoid-regulated kinase-1 gene expression by endothelin-1.
    Wolf SC; Schultze M; Risler T; Rieg T; Lang F; Schulze-Osthoff K; Brehm BR
    Biochem Pharmacol; 2006 Apr; 71(8):1175-83. PubMed ID: 16483548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS; Turgeon A; Schiffrin EL
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure.
    Mulder P; Richard V; Bouchart F; Derumeaux G; Münter K; Thuillez C
    Cardiovasc Res; 1998 Sep; 39(3):600-8. PubMed ID: 9861302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute effects of endothelin-1 and TAK-044 (ET(A) and ET(B) receptor antagonist) in rats with dilated cardiomyopathy.
    Watanabe K; Ohta Y; Kouda T; Sekiguchi T; Sato S; Nakazawa M; Hasegawa G; Naito M; Fuse K; Ito M; Hirono S; Tanabe N; Hanawa H; Kato K; Kodama M; Aizawa Y
    J Cardiovasc Pharmacol; 2000; 36 Suppl 2():S49-54. PubMed ID: 11206720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.